Wednesday, February 26, 2020 10:38:36 AM
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 11:05:20 AM
- Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 • GlobeNewswire Inc. • 11/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:30:37 PM
- Tonix Pharmaceuticals to Present at BIO-Europe® 2024 • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 09:16:22 PM
- Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 12:05:14 PM
- Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) • GlobeNewswire Inc. • 10/17/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/16/2024 01:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:05:35 PM
- Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:05:22 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/01/2024 04:15:07 AM
- Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAI • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 11:05:27 AM
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines • GlobeNewswire Inc. • 09/27/2024 11:00:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/23/2024 09:09:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:08:50 AM
- Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/20/2024 09:03:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 11:05:26 AM
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:23:27 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM